Ophiomics

About:

Ophiomics is clinical-stage Medtech company developing IVD devices (AI, genomics) for in oncology.

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs, BlueCrow Capital

Description:

Ophiomics is an ISO 13485 and ISO 9001 certified, clinical-stage Medtech company developing cutting-edge diagnostic products and services integrating bioinformatics, artificial intelligence and genomics in support of diagnostic, prognostic, treatment selection and clinical follow-up in oncology. It currently has a rich pipeline of products at different development stages, from pre-clinical programs to products undergoing clinical validation.

Total Funding Amount:

8.15M EUR

Headquarters Location:

Lisboa, Lisboa, Portugal

Founded Date:

2015-01-01

Contact Email:

info(AT)ophiomics.com

Founders:

Joana Cardoso Vaz, Jose Pereira Leal

Number of Employees:

11-50

Last Funding Date:

2023-01-18

IPO Status:

Private

Industries: